+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Indian Tissue Diagnostics Market 2019-2025

  • PDF Icon


  • March 2020
  • Region: India
  • Orion Market Research Private Limited
  • ID: 5013409
UP TO OFF until Dec 31st 2022
Indian Tissue Diagnostics Market Size, Share & Trends Analysis Report by Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology And Workflow Management, Special Staining and Hematoxylin & Eosin (H&E) Stain) By Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer and Non-small Cell Lung Carcinoma) By Product (Instruments and Consumables) By End-User (Hospitals, Pharmaceuticals, Research Institute, Laboratories, and Other Research) Forecast period 2019-2025.

Indian tissue diagnostics market is anticipated to grow at a CAGR 8.3% during the forecast period. Indian tissue diagnostics market is expected to grow at a significant rate due to favorable government policies, economic reforms, medical tourism, cohesive government regulations, rising cancer patients and growth of the diagnostic sector. Diagnostic centers are getting an overwhelming response from the patients across the region. Various hospital chains such as Apollo Hospitals and Global Healthcare Enterprise are growing significantly in India due to a huge prevalence of cancer and related diseases. Private hospitals are expanding their business to provide a wide range of diagnostic tests and applications to a massive pool of cancer patients including foreign patients during medical tourism.

Indian government investing considerable amount and effort to improve the healthcare system by strengthening district-level clinics and medical facilities in urban and country regions to boost the inclusive growth of the healthcare system. There are certain regulatory bodies that regulate diagnostic devices and other medical devices. They are responsible to provide quality healthcare devices and services to the patients. They ensure the safety and effectiveness of the devices without exposing patients to any risk. These regulatory bodies include the Central Drug Standard Control Organization (CDSCO), Government of India Directory of Health and Family Welfare, Indian Council of Medical Research (ICMR) and Ministry of Health and Family Welfare (MHFW).

The major market players that are active in the Indian tissue diagnostic market include Abbott Laboratories, Agilent technologies, Axxin, Becton, Dickinson and Co., Eurogentec S.A., GE Healthcare, Johnson & Johnson, Philips, Inc, QIAGEN AG, Roche Holdings AG and Siemens AG.

Research Methodology

The market study of the Indian Tissue Diagnostics market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the Healthcare industry and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Indian Tissue Diagnostics Market Research and Analysis by Technology
2. Indian Tissue Diagnostics Market Research and Analysis by Product
3. Indian Tissue Diagnostics Market Research and Analysis by Diseases
4. Indian Tissue Diagnostics Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the Indian Tissue Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Indian Tissue Diagnostics market.
  • Insights about market determinants which are stimulating the Indian Tissue Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Indian Tissue Diagnostics Market by Technology
5.1.1. Immunohistochemistry
5.1.2. In Situ Hybridization
5.1.3. Digital Pathology And Workflow Management
5.1.4. Special Staining
5.1.5. Hematoxylin & Eosin (H&E) Stain
5.2. Indian Tissue Diagnostics Market by Diseases
5.2.1. Breast Cancer
5.2.2. Gastric Cancer
5.2.3. Lymphoma
5.2.4. Prostate Cancer
5.2.5. Non-small Cell Lung Carcinoma
5.3. Indian Tissue Diagnostics Market by Product
5.3.1. Instruments
5.3.2. Consumables
5.4. Indian Tissue Diagnostics Market by End-User
5.4.1. Hospitals
5.4.2. Pharmaceuticals
5.4.3. Research Institute
5.4.4. Laboratories
5.4.5. Other Research
6. Company Profiles
6.1. Abbott Laboratories
6.2. Agilent technologies
6.3. Axxin
6.4. Becton, Dickinson and Co.,
6.5. Eurogentec S.A.
6.6. GE healthcare
6.7. Johnson & Johnson
6.8. Philips, Inc
6.10. Roche Holdings AG
6.11. Siemens AG

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Agilent technologies
  • Axxin
  • Becton, Dickinson and Co.,
  • Eurogentec S.A.
  • GE healthcare
  • Johnson & Johnson
  • Philips, Inc
  • Roche Holdings AG
  • Siemens AG